Arbutus Biopharma Corp SEC filings ABUS

Arbutus Biopharma Corp has 1,000 filings in SEC EDGAR's recent list, going back to Aug 9, 2011. Its latest annual report, Form 10-K, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (other events). The company's fiscal year ends on December 31.

Arbutus Biopharma Corp SEC filings
Form Description Filed Period
8-K Current report
Other events
Oct 22, 2026 Oct 20, 2026
SC TO-I/A Filing Oct 1, 2026 —
SC TO-I/A Filing Sep 30, 2026 —
SC TO-I Filing Aug 24, 2026 —
SC TO-C Filing Aug 21, 2026 —
8-K Current report
Other events
Aug 21, 2026 Aug 21, 2026
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 12, 2026 Aug 12, 2026
8-K Current report
Agreement ended, Officer or director change, Other events
Jul 16, 2026 Jul 15, 2026
S-8 Employee stock plan registration Jun 5, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
May 27, 2026 May 26, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
8-K Current report
Other events
Apr 15, 2026 Apr 14, 2026
DEFA14A Additional proxy material Apr 14, 2026 —
DEF 14A Proxy statement Apr 14, 2026 May 26, 2026
8-K Current report
Results of operations
Mar 23, 2026 Mar 23, 2026
10-K Annual report Mar 23, 2026 Dec 31, 2025
8-K Current report
Material agreement, Other events
Mar 3, 2026 Mar 3, 2026
8-K Current report
Other events
Feb 20, 2026 Feb 17, 2026
8-K Current report
Other events
Feb 6, 2026 Feb 2, 2026
8-K Current report
Other events
Jan 16, 2026 Jan 15, 2026
8-K Current report
Other events
Dec 11, 2025 Dec 11, 2025
8-K Current report
Results of operations, Other events
Nov 13, 2025 Nov 13, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Other events
Oct 7, 2025 Oct 7, 2025
8-K Current report
Other events
Sep 10, 2025 Sep 9, 2025
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations, Officer or director change, Other events
Aug 6, 2025 Aug 4, 2025
8-K Current report
Agreement ended, Other events
Jun 25, 2025 Jun 20, 2025
8-K Current report
Shareholder vote results
May 23, 2025 May 21, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 14, 2025 May 14, 2025
8-K Current report
Other events
May 7, 2025 May 7, 2025
8-K Current report
Other events
Apr 23, 2025 Apr 23, 2025
DEFA14A Additional proxy material Apr 4, 2025 —
DEF 14A Proxy statement Apr 4, 2025 May 21, 2025
8-K Current report
Officer or director change, Other events
Apr 3, 2025 Mar 28, 2025
10-K Annual report Mar 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 27, 2025 Mar 27, 2025
8-K Current report
Material agreement, Other events
Mar 3, 2025 Mar 3, 2025
8-K Current report
Officer or director change, Other events
Feb 25, 2025 Feb 24, 2025
8-K Current report
Results of operations, Other events
Jan 13, 2025 Jan 13, 2025
EFFECT Filing Dec 5, 2024 —
CORRESP Letter to the SEC Dec 2, 2024 —
8-K Current report
Other events
Nov 15, 2024 Nov 15, 2024
UPLOAD Letter from the SEC Nov 14, 2024 —
S-3 Shelf registration Nov 6, 2024 —
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations, Other events
Nov 6, 2024 Nov 6, 2024
8-K Current report
Other events
Oct 15, 2024 Oct 15, 2024
8-K Current report
Officer or director change
Oct 11, 2024 Oct 11, 2024
S-8 Employee stock plan registration Aug 8, 2024 —
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Regulation FD disclosure
Aug 5, 2024 Aug 5, 2024
8-K Current report
Results of operations, Other events
Aug 1, 2024 Aug 1, 2024
8-K Current report
Other events
Jun 6, 2024 Jun 6, 2024
8-K Current report
Other events
Jun 5, 2024 Jun 5, 2024
8-K Current report
Officer or director change, Shareholder vote results
May 28, 2024 May 22, 2024
8-K Current report
Other events
May 22, 2024 May 22, 2024
10-Q Quarterly report May 2, 2024 Mar 31, 2024
8-K Current report
Results of operations, Other events
May 2, 2024 May 2, 2024
8-K Current report
Officer or director change, Other events
May 2, 2024 May 1, 2024
DEFA14A Additional proxy material Apr 10, 2024 —
DEF 14A Proxy statement Apr 10, 2024 May 22, 2024
8-K Current report
Other events
Apr 4, 2024 Apr 4, 2024
10-K Annual report Mar 5, 2024 Dec 31, 2023
8-K Current report
Results of operations, Other events
Feb 29, 2024 Feb 29, 2024
8-K Current report
Results of operations, Other events
Jan 8, 2024 Jan 8, 2024
8-K Current report
Officer or director change
Jan 4, 2024 Dec 31, 2023
8-K Current report
Other events
Nov 9, 2023 Nov 9, 2023
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
8-K Current report
Results of operations, Other events
Nov 7, 2023 Nov 7, 2023
8-K Current report
Officer or director change
Nov 7, 2023 Nov 1, 2023
8-K Current report
Other events
Oct 11, 2023 Oct 11, 2023
8-K Current report
Other events
Sep 11, 2023 Sep 11, 2023
S-8 Employee stock plan registration Aug 3, 2023 —
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations, Other events
Aug 3, 2023 Aug 3, 2023
8-K Current report
Officer or director change
Jul 12, 2023 Jul 11, 2023
8-K Current report
Other events
Jul 10, 2023 Jul 10, 2023
8-K Current report
Other events
Jun 21, 2023 Jun 21, 2023
8-K Current report
Other events
Jun 21, 2023 Jun 21, 2023
8-K Current report
Other events
Jun 7, 2023 Jun 7, 2023
8-K Current report
Shareholder vote results
May 30, 2023 May 24, 2023
10-Q Quarterly report May 4, 2023 Mar 31, 2023
8-K Current report
Results of operations, Other events
May 4, 2023 May 4, 2023
8-K Current report
Other events
Apr 27, 2023 Apr 27, 2023
8-K Current report
Other events
Apr 25, 2023 Apr 25, 2023
8-K Current report
Other events
Apr 18, 2023 Apr 18, 2023
DEFA14A Additional proxy material Apr 12, 2023 —
DEF 14A Proxy statement Apr 12, 2023 May 24, 2023
8-K Current report
Other events
Apr 4, 2023 Apr 4, 2023
8-K Current report
Other events
Mar 16, 2023 Mar 16, 2023
8-K Current report
Other events
Mar 14, 2023 Mar 14, 2023
10-K Annual report Mar 2, 2023 Dec 31, 2022
8-K Current report
Results of operations, Other events
Mar 2, 2023 Mar 2, 2023
8-K Current report
Officer or director change
Jan 27, 2023 Jan 23, 2023
8-K Current report
Results of operations, Other events
Jan 5, 2023 Jan 5, 2023
8-K Current report
Other events
Dec 13, 2022 Dec 13, 2022
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022
8-K Current report
Results of operations, Other events
Nov 9, 2022 Nov 9, 2022
8-K Current report
Other events
Nov 4, 2022 Nov 4, 2022
8-K Current report
Other events
Nov 1, 2022 Nov 1, 2022
8-K Current report
Other events
Oct 31, 2022 Oct 31, 2022
8-K Current report
Officer or director change
Oct 24, 2022 Oct 18, 2022
8-K Current report
Other events
Sep 30, 2022 Sep 30, 2022
8-K Current report
Other events
Aug 30, 2022 Aug 30, 2022
S-8 Employee stock plan registration Aug 4, 2022 —
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
8-K Current report
Other events
Jul 20, 2022 Jul 20, 2022
8-K Current report
Other events
Jun 27, 2022 Jun 25, 2022
8-K Current report
Other events
Jun 8, 2022 Jun 8, 2022
8-K Current report
Other events
Jun 6, 2022 Jun 6, 2022
8-K Current report
Officer or director change, Shareholder vote results
May 31, 2022 May 25, 2022
8-K Current report
Other events
May 26, 2022 May 26, 2022
8-K Current report
Other events
May 24, 2022 May 24, 2022
10-Q Quarterly report May 5, 2022 Mar 31, 2022
8-K Current report
Results of operations, Other events
May 5, 2022 May 5, 2022
DEFA14A Additional proxy material Apr 11, 2022 —
DEF 14A Proxy statement Apr 11, 2022 May 25, 2022
8-K Current report
Other events
Mar 3, 2022 Mar 3, 2022
424B5 Prospectus supplement Mar 3, 2022 —
10-K Annual report Mar 3, 2022 Dec 31, 2021
8-K Current report
Results of operations, Other events
Mar 3, 2022 Mar 3, 2022
8-K Current report
Other events
Feb 28, 2022 Feb 28, 2022
8-K Current report
Results of operations, Other events
Jan 24, 2022 Jan 24, 2022
D Filing Dec 30, 2021 —
8-K Current report
Other events
Dec 14, 2021 Dec 14, 2021
8-K Current report
Material agreement, Other events
Dec 13, 2021 Dec 13, 2021
8-K Current report
Material agreement
Dec 10, 2021 Dec 9, 2021
8-K Current report
Other events
Dec 7, 2021 Dec 7, 2021
8-K Current report
Other events
Dec 1, 2021 Dec 1, 2021
EFFECT Filing Nov 18, 2021 —
CORRESP Letter to the SEC Nov 16, 2021 —
UPLOAD Letter from the SEC Nov 16, 2021 —
8-K Current report
Officer or director change
Nov 12, 2021 Nov 9, 2021
8-K Current report
Other events
Nov 12, 2021 Nov 10, 2021
S-3 Shelf registration Nov 4, 2021 —
10-Q Quarterly report Nov 4, 2021 Sep 30, 2021
8-K Current report
Results of operations, Other events
Nov 4, 2021 Nov 4, 2021
424B5 Prospectus supplement Oct 8, 2021 —
8-K Current report
Other events
Oct 8, 2021 Oct 8, 2021
S-8 Employee stock plan registration Aug 5, 2021 —
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
8-K Current report
Results of operations, Other events
Aug 5, 2021 Aug 5, 2021
8-K Current report
Other events
Jul 14, 2021 Jul 14, 2021
8-K Current report
Other events
Jul 7, 2021 Jul 7, 2021
8-K Current report
Other events
Jul 6, 2021 Jul 6, 2021
8-K Current report
Other events
Jun 29, 2021 Jun 29, 2021
8-K Current report
Other events
Jun 28, 2021 Jun 26, 2021
8-K Current report
Officer or director change, Shareholder vote results
Jun 1, 2021 May 26, 2021
10-Q Quarterly report May 5, 2021 Mar 31, 2021
8-K Current report
Results of operations, Other events
May 5, 2021 May 5, 2021
DEFA14A Additional proxy material Apr 8, 2021 —
DEF 14A Proxy statement Apr 8, 2021 May 26, 2021
8-K Current report
Other events
Apr 1, 2021 Apr 1, 2021
8-K Current report
Other events
Mar 16, 2021 Mar 16, 2021
8-K Current report
Material agreement
Mar 4, 2021 Mar 4, 2021
424B5 Prospectus supplement Mar 4, 2021 —
10-K Annual report Mar 4, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 4, 2021 Mar 4, 2021
8-K Current report
Other events
Feb 26, 2021 Feb 26, 2021
8-K Current report
Other events
Feb 1, 2021 Feb 1, 2021
8-K Current report
Results of operations, Other events
Jan 25, 2021 Jan 25, 2021
8-K Current report
Other events
Dec 10, 2020 Dec 10, 2020
8-K Current report
Other events
Nov 16, 2020 Nov 15, 2020
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
EFFECT Filing Oct 22, 2020 —
CORRESP Letter to the SEC Oct 21, 2020 —
8-K Current report
Other events
Sep 15, 2020 Sep 15, 2020
UPLOAD Letter from the SEC Sep 3, 2020 —
CT ORDER Filing Sep 1, 2020 —
S-3 Shelf registration Aug 28, 2020 —
8-K Current report
Other events
Aug 27, 2020 Aug 27, 2020
8-K Current report
Other events
Aug 10, 2020 Aug 10, 2020
8-K Current report
Material agreement
Aug 7, 2020 Aug 7, 2020
424B5 Prospectus supplement Aug 7, 2020 —
424B5 Prospectus supplement Aug 7, 2020 —
10-Q Quarterly report Aug 7, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 7, 2020 Aug 7, 2020
8-K Current report
Other events
Jul 24, 2020 Jul 23, 2020
CT ORDER Filing Jul 23, 2020 —
S-8 Employee stock plan registration Jun 24, 2020 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 1, 2020 Jun 1, 2020
8-K Current report
Other events
May 18, 2020 May 18, 2020
10-Q Quarterly report May 11, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 11, 2020 May 11, 2020
DEF 14A Proxy statement Apr 24, 2020 May 28, 2020
8-K Current report
Other events
Mar 26, 2020 Mar 26, 2020
10-K/A Amended annual report Mar 6, 2020 Dec 31, 2019
10-K Annual report Mar 5, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 5, 2020 Mar 5, 2020
8-K Current report
Officer or director change
Feb 19, 2020 Feb 19, 2020
8-K Current report
Other events
Feb 10, 2020 Feb 10, 2020
8-K Current report
Results of operations, Other events
Jan 13, 2020 Jan 13, 2020
EFFECT Filing Jan 10, 2020 —
CORRESP Letter to the SEC Jan 8, 2020 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ABUS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
British Columbia, Canada
Headquarters
Warminster, PA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1447028
Former names
TEKMIRA PHARMACEUTICALS CORP (until Aug 3, 2015); TEKMIRA PHARMACEUTICALS Corp (until Aug 3, 2015)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.